| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23155-532-01 | 23155-532 | HUMAN PRESCRIPTION DRUG | ETHOSUXIMIDE | ETHOSUXIMIDE | CAPSULE | ORAL | 20150909 | N/A | ANDA | ANDA200892 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ETHOSUXIMIDE | 250 mg/1 | 100 CAPSULE in 1 BOTTLE (23155-532-01) |
| 23155-532-05 | 23155-532 | HUMAN PRESCRIPTION DRUG | ETHOSUXIMIDE | ETHOSUXIMIDE | CAPSULE | ORAL | 20150909 | N/A | ANDA | ANDA200892 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ETHOSUXIMIDE | 250 mg/1 | 500 CAPSULE in 1 BOTTLE (23155-532-05) |
| 62135-790-12 | 62135-790 | HUMAN PRESCRIPTION DRUG | ETHOSUXIMIDE | ETHOSUXIMIDE | CAPSULE | ORAL | 20231023 | N/A | ANDA | ANDA200892 | Chartwell RX, LLC | ETHOSUXIMIDE | 250 mg/1 | 120 CAPSULE in 1 BOTTLE (62135-790-12) |